from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3141/fadB4

LFCtreatmentdescriptionclass of inhibitor

-0.149

Amikacinug/mL Amikacintranslation

0.137

Cap5-10ug/mL Capreomycintranslation

-0.471

Rox10-50 ug/mL Roxithromycintranslation

-0.123

SM2-5 ug/mL Streptomycintranslation

0.929

Tet5-10 ug/mL Tetracyclinetranslation

0.947

Rif0.2-5ug/mL Rifampicintranscription

-0.109

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.091

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.150

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.937

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.842

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.203

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.325

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.551

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.427

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.198

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.114

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.798

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.486

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.558

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.506

KCN5-20 ug/mL Potassium cyaniderespiration

0.682

NaN30.2-2 mM Sodium aziderespiration

-0.098

Nigericin50 uM Nigericinrespiration

0.361

TRC10-150 ug/mL Triclosanrespiration

0.534

TRZ10-25 ug/mL Thioridazinerespiration

0.987

Valinomycin0.5-10 uM Valinomycinrespiration

-0.538

ZnSO42 mM ZnSO4respiration

0.341

menadione6-10 ug/mL Menadionerespiration

0.725

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.185

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.507

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.553

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.453

NRP_1Non-replicating persistence stage 1dosRassociated

-0.653

Amp0.2mg/mL AmpicillincellWall

-0.021

Cephalexin20-100 ug/mL CephalexincellWall

-0.006

Cerulenin0.32-5 ug/mL CerulenincellWall

0.217

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.192

EMB10-20 ug/mL EthambutolcellWall

-0.302

Eta12-40 ug/mL EthionamidecellWall

-0.166

INH0.2-0.4 ug/mL IsoniazidcellWall

0.115

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.058

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.303

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.094

BZA0.12 mg/mL BenzamidearomaticAmides

-0.932

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.562

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.385

H2O24 mM hydrogen peroxideDNAdamaging

-0.074

Levo10 ug/mL LevofloxacinDNAdamaging

-1.309

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.428

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.397

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.954

UVUV-irradiationDNAdamaging

-0.369

ARP41-4 ug/mL Antitubercular compound ARP4?

0.574

Antimycin12.5-50 ug/mL Antimycin A?

-0.269

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.120

PA_110-50 ug/mL Antitubercular compound PA-1?

1.065

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.538

PA8240.2-2 ug/mL PA-824?

0.532

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.731

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.133

Verapamil50 uM Verapamil?

0.482

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.251

methoxatin10-20 ug/mL Methoxatin?